Our Story

Follicle & Co. was born out of obsession — not with hair loss, but with formulation science.

How It Started

We asked a simple question

We spent months studying every clinical trial we could find. Proprietary peptide complexes. Delivery mechanisms. Growth factor signaling pathways.

The more we learned, the clearer it became: the science exists. The active ingredients are available. The clinical data is published. The only thing standing between consumers and clinical-grade results was a business model built on clinic markups and gatekeeping.

So we asked a simple question: Why can’t this exist at home?

The answer was: it can. Nobody was building it.

What We Built

Formula first. Everything else second.

We started with the formula, not the brand. The full RCP trio — Redensyl at 3%, Capixyl at 2.5%, Procapil at 2.5% — targeting DHT modulation, stem cell activation, and follicle anchoring.

Every active ingredient is dosed at the concentration used in published studies. We publish those percentages on the label because hiding behind “proprietary blends” is how brands get away with pixie-dusting trace amounts of expensive ingredients.

Then we paired the formula with 0.5mm microneedle delivery. No filler ingredients to pad an INCI list. Total active load: 12%, published and verified.

What We Stand For

Five principles. No exceptions.

Transparency over marketing

We publish what’s in it and how much. Every ingredient, every percentage, every time.

Science over hype

Every claim is backed by a mechanism or a study. We don’t use words like “miracle” or “breakthrough.”

Access over gatekeeping

Clinical-grade formulations shouldn’t require a clinic visit and a $300 invoice.

Honesty over conversion

We’d rather lose a sale than make a false promise. Hair growth takes months. Not everyone will respond.

Product over brand

We invest in the formula, not the influencer. The ingredient list is the marketing.

What’s Next

Built on research. Guided by it too.

Every ingredient in our formula is dosed at concentrations validated in peer-reviewed clinical research. We didn’t guess — we followed the science.

A proprietary trial on the complete formulation is on the roadmap. We’ll share the data when it’s ready.